English
简体中文
Total: £ 56.28
Published Date: 2026-05-15 | Pages: 116 | Tables: 111 | Medical Devices & Consumables
The global Hyperthermic Chemotherapy Perfusion Equipment market was valued at US$ 45.15 million in 2025 and is anticipated to reach US$ 62.93 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hyperthermic Chemotherapy Perfusion Equipment competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
A Hyperthermic Chemotherapy Perfusion Equipment, also known as a hyperthermic perfusion system or hyperthermic chemotherapy delivery system, is a medical device designed to administer chemotherapy drugs at an elevated temperature directly to a specific area of the body. This treatment approach is used in various medical contexts, including hyperthermic intraperitoneal chemotherapy (HIPEC) and hyperthermic limb perfusion (HILP), to enhance the effectiveness of chemotherapy in treating cancer. Temperature Control Unit is responsible for heating and maintaining the chemotherapy solution at a precise and elevated temperature. In HIPEC, for example, the temperature is typically maintained in the range of 41-43 degrees Celsius (105-109 degrees Fahrenheit). The controlled hyperthermia is an essential aspect of the treatment's effectiveness.Hyperthermic Chemotherapy Perfusion Equipments are used in highly specialized medical procedures and are typically operated by trained medical professionals, including surgeons and anesthesia providers. The price of the main unit for Hyperthermic Chemotherapy Perfusion Equipment typically ranges from approximately US$70,000 to US$150,000 per unit.
The upstream supply chain for Hyperthermic Chemotherapy Perfusion Equipment mainly includes medical-grade pumps, heat exchangers, temperature sensors, pressure monitoring components, control systems, tubing sets, reservoirs, filters, sterile disposable kits, and biocompatible materials that meet medical device standards. Key manufacturing capabilities are concentrated in fluid temperature control, stable perfusion flow, real-time monitoring, sterility assurance, and system safety design. Downstream demand mainly comes from hospitals, cancer centers, surgical oncology departments, and specialized HIPEC treatment centers, where the equipment is used during cytoreductive surgery to circulate heated chemotherapy solution within the abdominal cavity. Market demand is closely linked to the clinical adoption of HIPEC procedures, hospital investment in oncology surgery capabilities, availability of trained surgical teams, and the recurring use of disposable procedure kits for each treatment.
The North American market for Hyperthermic Chemotherapy Perfusion Equipment is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Hyperthermic Chemotherapy Perfusion Equipment is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Hyperthermic Chemotherapy Perfusion Equipment include ThermaSolutions, Gamida Tech, RanD Biotech, Belmont Medical Technologies, Combat Medical, Medica, Morestep Medical, Guangzhou BRM, Shenzhen Cooper Medical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Hyperthermic Chemotherapy Perfusion Equipment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hyperthermic Chemotherapy Perfusion Equipment. The Hyperthermic Chemotherapy Perfusion Equipment market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Hyperthermic Chemotherapy Perfusion Equipment market comprehensively. Regional market sizes by Type, by Application, by Perfusion Method, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Hyperthermic Chemotherapy Perfusion Equipment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
ThermaSolutions
Gamida Tech
RanD Biotech
Belmont Medical Technologies
Combat Medical
Medica
Morestep Medical
Guangzhou BRM
Shenzhen Cooper Medical
Segment by Type
Integrated HIPEC Systems
Modular HIPEC Systems
Segment by Perfusion Method
Open HIPEC System
Closed HIPEC System
Hybrid HIPEC System
by Application
Colorectal Cancer
Ovarian Cancer
Gastric Cancer
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Perfusion Method, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Hyperthermic Chemotherapy Perfusion Equipment manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Hyperthermic Chemotherapy Perfusion Equipment sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Hyperthermic Chemotherapy Perfusion Equipment Market Overview
1.1 Product Definition
1.2 Hyperthermic Chemotherapy Perfusion Equipment by Type
1.2.1 Global Hyperthermic Chemotherapy Perfusion Equipment Market Value by Type: 2025 vs 2032
1.2.2 Integrated HIPEC Systems
1.2.3 Modular HIPEC Systems
1.3 Hyperthermic Chemotherapy Perfusion Equipment by Perfusion Method
1.3.1 Global Hyperthermic Chemotherapy Perfusion Equipment Market Value by Perfusion Method: 2025 vs 2032
1.3.2 Open HIPEC System
1.3.3 Closed HIPEC System
1.3.4 Hybrid HIPEC System
1.4 Hyperthermic Chemotherapy Perfusion Equipment by Application
1.4.1 Global Hyperthermic Chemotherapy Perfusion Equipment Market Value by Application: 2025 vs 2032
1.4.2 Colorectal Cancer
1.4.3 Ovarian Cancer
1.4.4 Gastric Cancer
1.4.5 Others
1.5 Global Hyperthermic Chemotherapy Perfusion Equipment Market Size Estimates and Forecasts
1.5.1 Global Hyperthermic Chemotherapy Perfusion Equipment Revenue 2021–2032
1.5.2 Global Hyperthermic Chemotherapy Perfusion Equipment Sales 2021–2032
1.5.3 Global Hyperthermic Chemotherapy Perfusion Equipment Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 Hyperthermic Chemotherapy Perfusion Equipment Market Competition by Manufacturers
2.1 Global Hyperthermic Chemotherapy Perfusion Equipment Sales Market Share by Manufacturers (2021–2026)
2.2 Global Hyperthermic Chemotherapy Perfusion Equipment Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Hyperthermic Chemotherapy Perfusion Equipment Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Hyperthermic Chemotherapy Perfusion Equipment, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Hyperthermic Chemotherapy Perfusion Equipment, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Hyperthermic Chemotherapy Perfusion Equipment, Product Types and Applications
2.7 Global Key Manufacturers of Hyperthermic Chemotherapy Perfusion Equipment, Date of Entry into the Industry
2.8 Global Hyperthermic Chemotherapy Perfusion Equipment Market Competitive Situation and Trends
2.8.1 Global Hyperthermic Chemotherapy Perfusion Equipment Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Hyperthermic Chemotherapy Perfusion Equipment Players Market Share by Revenue
2.8.3 Global Hyperthermic Chemotherapy Perfusion Equipment Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hyperthermic Chemotherapy Perfusion Equipment Market Scenario by Region
3.1 Global Hyperthermic Chemotherapy Perfusion Equipment Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Hyperthermic Chemotherapy Perfusion Equipment Sales by Region: 2021–2032
3.2.1 Global Hyperthermic Chemotherapy Perfusion Equipment Sales by Region: 2021–2026
3.2.2 Global Hyperthermic Chemotherapy Perfusion Equipment Sales by Region: 2027–2032
3.3 Global Hyperthermic Chemotherapy Perfusion Equipment Revenue by Region: 2021–2032
3.3.1 Global Hyperthermic Chemotherapy Perfusion Equipment Revenue by Region: 2021–2026
3.3.2 Global Hyperthermic Chemotherapy Perfusion Equipment Revenue by Region: 2027–2032
3.4 North America Hyperthermic Chemotherapy Perfusion Equipment Market Facts & Figures by Country
3.4.1 North America Hyperthermic Chemotherapy Perfusion Equipment Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Hyperthermic Chemotherapy Perfusion Equipment Sales by Country (2021–2032)
3.4.3 North America Hyperthermic Chemotherapy Perfusion Equipment Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hyperthermic Chemotherapy Perfusion Equipment Market Facts & Figures by Country
3.5.1 Europe Hyperthermic Chemotherapy Perfusion Equipment Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Hyperthermic Chemotherapy Perfusion Equipment Sales by Country (2021–2032)
3.5.3 Europe Hyperthermic Chemotherapy Perfusion Equipment Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hyperthermic Chemotherapy Perfusion Equipment Market Facts & Figures by Region
3.6.1 Asia Pacific Hyperthermic Chemotherapy Perfusion Equipment Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Hyperthermic Chemotherapy Perfusion Equipment Sales by Region (2021–2032)
3.6.3 Asia Pacific Hyperthermic Chemotherapy Perfusion Equipment Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Hyperthermic Chemotherapy Perfusion Equipment Market Facts & Figures by Country
3.7.1 Latin America Hyperthermic Chemotherapy Perfusion Equipment Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Hyperthermic Chemotherapy Perfusion Equipment Sales by Country (2021–2032)
3.7.3 Latin America Hyperthermic Chemotherapy Perfusion Equipment Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Hyperthermic Chemotherapy Perfusion Equipment Market Facts & Figures by Country
3.8.1 Middle East and Africa Hyperthermic Chemotherapy Perfusion Equipment Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Hyperthermic Chemotherapy Perfusion Equipment Sales by Country (2021–2032)
3.8.3 Middle East and Africa Hyperthermic Chemotherapy Perfusion Equipment Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hyperthermic Chemotherapy Perfusion Equipment Sales by Type (2021–2032)
4.1.1 Global Hyperthermic Chemotherapy Perfusion Equipment Sales by Type (2021–2026)
4.1.2 Global Hyperthermic Chemotherapy Perfusion Equipment Sales by Type (2027–2032)
4.1.3 Global Hyperthermic Chemotherapy Perfusion Equipment Sales Market Share by Type (2021–2032)
4.2 Global Hyperthermic Chemotherapy Perfusion Equipment Revenue by Type (2021–2032)
4.2.1 Global Hyperthermic Chemotherapy Perfusion Equipment Revenue by Type (2021–2026)
4.2.2 Global Hyperthermic Chemotherapy Perfusion Equipment Revenue by Type (2027–2032)
4.2.3 Global Hyperthermic Chemotherapy Perfusion Equipment Revenue Market Share by Type (2021–2032)
4.3 Global Hyperthermic Chemotherapy Perfusion Equipment Price by Type (2021–2032)
5 Segment by Application
5.1 Global Hyperthermic Chemotherapy Perfusion Equipment Sales by Application (2021–2032)
5.1.1 Global Hyperthermic Chemotherapy Perfusion Equipment Sales by Application (2021–2026)
5.1.2 Global Hyperthermic Chemotherapy Perfusion Equipment Sales by Application (2027–2032)
5.1.3 Global Hyperthermic Chemotherapy Perfusion Equipment Sales Market Share by Application (2021–2032)
5.2 Global Hyperthermic Chemotherapy Perfusion Equipment Revenue by Application (2021–2032)
5.2.1 Global Hyperthermic Chemotherapy Perfusion Equipment Revenue by Application (2021–2026)
5.2.2 Global Hyperthermic Chemotherapy Perfusion Equipment Revenue by Application (2027–2032)
5.2.3 Global Hyperthermic Chemotherapy Perfusion Equipment Revenue Market Share by Application (2021–2032)
5.3 Global Hyperthermic Chemotherapy Perfusion Equipment Price by Application (2021–2032)
6 Key Companies Profiled
6.1 ThermaSolutions
6.1.1 ThermaSolutions Company Information
6.1.2 ThermaSolutions Description and Business Overview
6.1.3 ThermaSolutions Hyperthermic Chemotherapy Perfusion Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 ThermaSolutions Hyperthermic Chemotherapy Perfusion Equipment Product Portfolio
6.1.5 ThermaSolutions Recent Developments/Updates
6.2 Gamida Tech
6.2.1 Gamida Tech Company Information
6.2.2 Gamida Tech Description and Business Overview
6.2.3 Gamida Tech Hyperthermic Chemotherapy Perfusion Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Gamida Tech Hyperthermic Chemotherapy Perfusion Equipment Product Portfolio
6.2.5 Gamida Tech Recent Developments/Updates
6.3 RanD Biotech
6.3.1 RanD Biotech Company Information
6.3.2 RanD Biotech Description and Business Overview
6.3.3 RanD Biotech Hyperthermic Chemotherapy Perfusion Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 RanD Biotech Hyperthermic Chemotherapy Perfusion Equipment Product Portfolio
6.3.5 RanD Biotech Recent Developments/Updates
6.4 Belmont Medical Technologies
6.4.1 Belmont Medical Technologies Company Information
6.4.2 Belmont Medical Technologies Description and Business Overview
6.4.3 Belmont Medical Technologies Hyperthermic Chemotherapy Perfusion Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Belmont Medical Technologies Hyperthermic Chemotherapy Perfusion Equipment Product Portfolio
6.4.5 Belmont Medical Technologies Recent Developments/Updates
6.5 Combat Medical
6.5.1 Combat Medical Company Information
6.5.2 Combat Medical Description and Business Overview
6.5.3 Combat Medical Hyperthermic Chemotherapy Perfusion Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Combat Medical Hyperthermic Chemotherapy Perfusion Equipment Product Portfolio
6.5.5 Combat Medical Recent Developments/Updates
6.6 Medica
6.6.1 Medica Company Information
6.6.2 Medica Description and Business Overview
6.6.3 Medica Hyperthermic Chemotherapy Perfusion Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Medica Hyperthermic Chemotherapy Perfusion Equipment Product Portfolio
6.6.5 Medica Recent Developments/Updates
6.7 Morestep Medical
6.7.1 Morestep Medical Company Information
6.7.2 Morestep Medical Description and Business Overview
6.7.3 Morestep Medical Hyperthermic Chemotherapy Perfusion Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Morestep Medical Hyperthermic Chemotherapy Perfusion Equipment Product Portfolio
6.7.5 Morestep Medical Recent Developments/Updates
6.8 Guangzhou BRM
6.8.1 Guangzhou BRM Company Information
6.8.2 Guangzhou BRM Description and Business Overview
6.8.3 Guangzhou BRM Hyperthermic Chemotherapy Perfusion Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Guangzhou BRM Hyperthermic Chemotherapy Perfusion Equipment Product Portfolio
6.8.5 Guangzhou BRM Recent Developments/Updates
6.9 Shenzhen Cooper Medical
6.9.1 Shenzhen Cooper Medical Company Information
6.9.2 Shenzhen Cooper Medical Description and Business Overview
6.9.3 Shenzhen Cooper Medical Hyperthermic Chemotherapy Perfusion Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Shenzhen Cooper Medical Hyperthermic Chemotherapy Perfusion Equipment Product Portfolio
6.9.5 Shenzhen Cooper Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hyperthermic Chemotherapy Perfusion Equipment Industry Chain Analysis
7.2 Hyperthermic Chemotherapy Perfusion Equipment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hyperthermic Chemotherapy Perfusion Equipment Production Mode & Process Analysis
7.4 Hyperthermic Chemotherapy Perfusion Equipment Sales and Marketing
7.4.1 Hyperthermic Chemotherapy Perfusion Equipment Sales Channels
7.4.2 Hyperthermic Chemotherapy Perfusion Equipment Distributors
7.5 Hyperthermic Chemotherapy Perfusion Equipment Customer Analysis
8 Hyperthermic Chemotherapy Perfusion Equipment Market Dynamics
8.1 Hyperthermic Chemotherapy Perfusion Equipment Industry Trends
8.2 Hyperthermic Chemotherapy Perfusion Equipment Market Drivers
8.3 Hyperthermic Chemotherapy Perfusion Equipment Market Challenges
8.4 Hyperthermic Chemotherapy Perfusion Equipment Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Hyperthermic Chemotherapy Perfusion Equipment Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Hyperthermic Chemotherapy Perfusion Equipment Market Value by Perfusion Method (US$ Million), 2025 vs 2032
Table 3. Global Hyperthermic Chemotherapy Perfusion Equipment Market Value by Application (US$ Million), 2025 vs 2032
Table 4. Global Hyperthermic Chemotherapy Perfusion Equipment Market Competitive Situation by Manufacturers in 2025
Table 5. Global Hyperthermic Chemotherapy Perfusion Equipment Sales (Units) of Key Manufacturers (2021–2026)
Table 6. Global Hyperthermic Chemotherapy Perfusion Equipment Sales Market Share by Manufacturers (2021–2026)
Table 7. Global Hyperthermic Chemotherapy Perfusion Equipment Revenue (US$ Million) by Manufacturers (2021–2026)
Table 8. Global Hyperthermic Chemotherapy Perfusion Equipment Revenue Share by Manufacturers (2021–2026)
Table 9. Global Market Hyperthermic Chemotherapy Perfusion Equipment Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 10. Global Key Players of Hyperthermic Chemotherapy Perfusion Equipment, Industry Ranking, 2023 vs 2024 vs 2025
Table 11. Global Key Manufacturers of Hyperthermic Chemotherapy Perfusion Equipment, Manufacturing Sites and Headquarters
Table 12. Global Key Manufacturers of Hyperthermic Chemotherapy Perfusion Equipment, Product Types and Applications
Table 13. Global Key Manufacturers of Hyperthermic Chemotherapy Perfusion Equipment, Date of Entry into the Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Hyperthermic Chemotherapy Perfusion Equipment Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hyperthermic Chemotherapy Perfusion Equipment Revenue, 2025
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global Hyperthermic Chemotherapy Perfusion Equipment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 18. Global Hyperthermic Chemotherapy Perfusion Equipment Sales by Region (Units), 2021–2026
Table 19. Global Hyperthermic Chemotherapy Perfusion Equipment Sales Market Share by Region (2021–2026)
Table 20. Global Hyperthermic Chemotherapy Perfusion Equipment Sales by Region (Units), 2027–2032
Table 21. Global Hyperthermic Chemotherapy Perfusion Equipment Sales Market Share by Region (2027–2032)
Table 22. Global Hyperthermic Chemotherapy Perfusion Equipment Revenue by Region (US$ Million), 2021–2026
Table 23. Global Hyperthermic Chemotherapy Perfusion Equipment Revenue Market Share by Region (2021–2026)
Table 24. Global Hyperthermic Chemotherapy Perfusion Equipment Revenue by Region (US$ Million), 2027–2032
Table 25. Global Hyperthermic Chemotherapy Perfusion Equipment Revenue Market Share by Region (2027–2032)
Table 26. North America Hyperthermic Chemotherapy Perfusion Equipment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 27. North America Hyperthermic Chemotherapy Perfusion Equipment Sales by Country (Units), 2021–2026
Table 28. North America Hyperthermic Chemotherapy Perfusion Equipment Sales by Country (Units), 2027–2032
Table 29. North America Hyperthermic Chemotherapy Perfusion Equipment Revenue by Country (US$ Million), 2021–2026
Table 30. North America Hyperthermic Chemotherapy Perfusion Equipment Revenue by Country (US$ Million), 2027–2032
Table 31. Europe Hyperthermic Chemotherapy Perfusion Equipment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 32. Europe Hyperthermic Chemotherapy Perfusion Equipment Sales by Country (Units), 2021–2026
Table 33. Europe Hyperthermic Chemotherapy Perfusion Equipment Sales by Country (Units), 2027–2032
Table 34. Europe Hyperthermic Chemotherapy Perfusion Equipment Revenue by Country (US$ Million), 2021–2026
Table 35. Europe Hyperthermic Chemotherapy Perfusion Equipment Revenue by Country (US$ Million), 2027–2032
Table 36. Asia Pacific Hyperthermic Chemotherapy Perfusion Equipment Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 37. Asia Pacific Hyperthermic Chemotherapy Perfusion Equipment Sales by Region (Units), 2021–2026
Table 38. Asia Pacific Hyperthermic Chemotherapy Perfusion Equipment Sales by Region (Units), 2027–2032
Table 39. Asia Pacific Hyperthermic Chemotherapy Perfusion Equipment Revenue by Region (US$ Million), 2021–2026
Table 40. Asia Pacific Hyperthermic Chemotherapy Perfusion Equipment Revenue by Region (US$ Million), 2027–2032
Table 41. Latin America Hyperthermic Chemotherapy Perfusion Equipment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 42. Latin America Hyperthermic Chemotherapy Perfusion Equipment Sales by Country (Units), 2021–2026
Table 43. Latin America Hyperthermic Chemotherapy Perfusion Equipment Sales by Country (Units), 2027–2032
Table 44. Latin America Hyperthermic Chemotherapy Perfusion Equipment Revenue by Country (US$ Million), 2021–2026
Table 45. Latin America Hyperthermic Chemotherapy Perfusion Equipment Revenue by Country (US$ Million), 2027–2032
Table 46. Middle East and Africa Hyperthermic Chemotherapy Perfusion Equipment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 47. Middle East and Africa Hyperthermic Chemotherapy Perfusion Equipment Sales by Country (Units), 2021–2026
Table 48. Middle East and Africa Hyperthermic Chemotherapy Perfusion Equipment Sales by Country (Units), 2027–2032
Table 49. Middle East and Africa Hyperthermic Chemotherapy Perfusion Equipment Revenue by Country (US$ Million), 2021–2026
Table 50. Middle East and Africa Hyperthermic Chemotherapy Perfusion Equipment Revenue by Country (US$ Million), 2027–2032
Table 51. Global Hyperthermic Chemotherapy Perfusion Equipment Sales (Units) by Type (2021–2026)
Table 52. Global Hyperthermic Chemotherapy Perfusion Equipment Sales (Units) by Type (2027–2032)
Table 53. Global Hyperthermic Chemotherapy Perfusion Equipment Sales Market Share by Type (2021–2026)
Table 54. Global Hyperthermic Chemotherapy Perfusion Equipment Sales Market Share by Type (2027–2032)
Table 55. Global Hyperthermic Chemotherapy Perfusion Equipment Revenue (US$ Million) by Type (2021–2026)
Table 56. Global Hyperthermic Chemotherapy Perfusion Equipment Revenue (US$ Million) by Type (2027–2032)
Table 57. Global Hyperthermic Chemotherapy Perfusion Equipment Revenue Market Share by Type (2021–2026)
Table 58. Global Hyperthermic Chemotherapy Perfusion Equipment Revenue Market Share by Type (2027–2032)
Table 59. Global Hyperthermic Chemotherapy Perfusion Equipment Price (US$/Unit) by Type (2021–2026)
Table 60. Global Hyperthermic Chemotherapy Perfusion Equipment Price (US$/Unit) by Type (2027–2032)
Table 61. Global Hyperthermic Chemotherapy Perfusion Equipment Sales (Units) by Application (2021–2026)
Table 62. Global Hyperthermic Chemotherapy Perfusion Equipment Sales (Units) by Application (2027–2032)
Table 63. Global Hyperthermic Chemotherapy Perfusion Equipment Sales Market Share by Application (2021–2026)
Table 64. Global Hyperthermic Chemotherapy Perfusion Equipment Sales Market Share by Application (2027–2032)
Table 65. Global Hyperthermic Chemotherapy Perfusion Equipment Revenue (US$ Million) by Application (2021–2026)
Table 66. Global Hyperthermic Chemotherapy Perfusion Equipment Revenue (US$ Million) by Application (2027–2032)
Table 67. Global Hyperthermic Chemotherapy Perfusion Equipment Revenue Market Share by Application (2021–2026)
Table 68. Global Hyperthermic Chemotherapy Perfusion Equipment Revenue Market Share by Application (2027–2032)
Table 69. Global Hyperthermic Chemotherapy Perfusion Equipment Price (US$/Unit) by Application (2021–2026)
Table 70. Global Hyperthermic Chemotherapy Perfusion Equipment Price (US$/Unit) by Application (2027–2032)
Table 71. ThermaSolutions Company Information
Table 72. ThermaSolutions Description and Business Overview
Table 73. ThermaSolutions Hyperthermic Chemotherapy Perfusion Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 74. ThermaSolutions Hyperthermic Chemotherapy Perfusion Equipment Product
Table 75. ThermaSolutions Recent Developments/Updates
Table 76. Gamida Tech Company Information
Table 77. Gamida Tech Description and Business Overview
Table 78. Gamida Tech Hyperthermic Chemotherapy Perfusion Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 79. Gamida Tech Hyperthermic Chemotherapy Perfusion Equipment Product
Table 80. Gamida Tech Recent Developments/Updates
Table 81. RanD Biotech Company Information
Table 82. RanD Biotech Description and Business Overview
Table 83. RanD Biotech Hyperthermic Chemotherapy Perfusion Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 84. RanD Biotech Hyperthermic Chemotherapy Perfusion Equipment Product
Table 85. RanD Biotech Recent Developments/Updates
Table 86. Belmont Medical Technologies Company Information
Table 87. Belmont Medical Technologies Description and Business Overview
Table 88. Belmont Medical Technologies Hyperthermic Chemotherapy Perfusion Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 89. Belmont Medical Technologies Hyperthermic Chemotherapy Perfusion Equipment Product
Table 90. Belmont Medical Technologies Recent Developments/Updates
Table 91. Combat Medical Company Information
Table 92. Combat Medical Description and Business Overview
Table 93. Combat Medical Hyperthermic Chemotherapy Perfusion Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 94. Combat Medical Hyperthermic Chemotherapy Perfusion Equipment Product
Table 95. Combat Medical Recent Developments/Updates
Table 96. Medica Company Information
Table 97. Medica Description and Business Overview
Table 98. Medica Hyperthermic Chemotherapy Perfusion Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 99. Medica Hyperthermic Chemotherapy Perfusion Equipment Product
Table 100. Medica Recent Developments/Updates
Table 101. Morestep Medical Company Information
Table 102. Morestep Medical Description and Business Overview
Table 103. Morestep Medical Hyperthermic Chemotherapy Perfusion Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 104. Morestep Medical Hyperthermic Chemotherapy Perfusion Equipment Product
Table 105. Morestep Medical Recent Developments/Updates
Table 106. Guangzhou BRM Company Information
Table 107. Guangzhou BRM Description and Business Overview
Table 108. Guangzhou BRM Hyperthermic Chemotherapy Perfusion Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 109. Guangzhou BRM Hyperthermic Chemotherapy Perfusion Equipment Product
Table 110. Guangzhou BRM Recent Developments/Updates
Table 111. Shenzhen Cooper Medical Company Information
Table 112. Shenzhen Cooper Medical Description and Business Overview
Table 113. Shenzhen Cooper Medical Hyperthermic Chemotherapy Perfusion Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 114. Shenzhen Cooper Medical Hyperthermic Chemotherapy Perfusion Equipment Product
Table 115. Shenzhen Cooper Medical Recent Developments/Updates
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Hyperthermic Chemotherapy Perfusion Equipment Distributors List
Table 119. Hyperthermic Chemotherapy Perfusion Equipment Customers List
Table 120. Hyperthermic Chemotherapy Perfusion Equipment Market Trends
Table 121. Hyperthermic Chemotherapy Perfusion Equipment Market Drivers
Table 122. Hyperthermic Chemotherapy Perfusion Equipment Market Challenges
Table 123. Hyperthermic Chemotherapy Perfusion Equipment Market Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 127. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hyperthermic Chemotherapy Perfusion Equipment
Figure 2. Global Hyperthermic Chemotherapy Perfusion Equipment Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Hyperthermic Chemotherapy Perfusion Equipment Market Share by Type: 2025 & 2032
Figure 4. Integrated HIPEC Systems Product Picture
Figure 5. Modular HIPEC Systems Product Picture
Figure 6. Global Hyperthermic Chemotherapy Perfusion Equipment Market Value by Perfusion Method (US$ Million), 2021–2032
Figure 7. Global Hyperthermic Chemotherapy Perfusion Equipment Market Share by Perfusion Method: 2025 vs 2032
Figure 8. Open HIPEC System Product Picture
Figure 9. Closed HIPEC System Product Picture
Figure 10. Hybrid HIPEC System Product Picture
Figure 11. Global Hyperthermic Chemotherapy Perfusion Equipment Market Value by Application (US$ Million), 2021–2032
Figure 12. Global Hyperthermic Chemotherapy Perfusion Equipment Market Share by Application: 2025 & 2032
Figure 13. Colorectal Cancer
Figure 14. Ovarian Cancer
Figure 15. Gastric Cancer
Figure 16. Others
Figure 17. Global Hyperthermic Chemotherapy Perfusion Equipment Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Hyperthermic Chemotherapy Perfusion Equipment Market Size (US$ Million), 2021–2032
Figure 19. Global Hyperthermic Chemotherapy Perfusion Equipment Sales (Units), 2021–2032
Figure 20. Global Hyperthermic Chemotherapy Perfusion Equipment Average Price (US$/Unit), 2021–2032
Figure 21. Hyperthermic Chemotherapy Perfusion Equipment Report Years Considered
Figure 22. Hyperthermic Chemotherapy Perfusion Equipment Sales Share by Manufacturers in 2025
Figure 23. Global Hyperthermic Chemotherapy Perfusion Equipment Revenue Share by Manufacturers in 2025
Figure 24. Top 5 and Top 10 Global Hyperthermic Chemotherapy Perfusion Equipment Players: Market Share by Revenue in Hyperthermic Chemotherapy Perfusion Equipment in 2025
Figure 25. Hyperthermic Chemotherapy Perfusion Equipment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 26. Global Hyperthermic Chemotherapy Perfusion Equipment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 27. North America Hyperthermic Chemotherapy Perfusion Equipment Sales Market Share by Country (2021–2032)
Figure 28. North America Hyperthermic Chemotherapy Perfusion Equipment Revenue Market Share by Country (2021–2032)
Figure 29. United States Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Canada Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Europe Hyperthermic Chemotherapy Perfusion Equipment Sales Market Share by Country (2021–2032)
Figure 32. Europe Hyperthermic Chemotherapy Perfusion Equipment Revenue Market Share by Country (2021–2032)
Figure 33. Germany Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. France Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. U.K. Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Italy Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Russia Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Asia Pacific Hyperthermic Chemotherapy Perfusion Equipment Sales Market Share by Region (2021–2032)
Figure 39. Asia Pacific Hyperthermic Chemotherapy Perfusion Equipment Revenue Market Share by Region (2021–2032)
Figure 40. China Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Japan Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. South Korea Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. India Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Australia Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. China Taiwan Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Southeast Asia Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Latin America Hyperthermic Chemotherapy Perfusion Equipment Sales Market Share by Country (2021–2032)
Figure 48. Latin America Hyperthermic Chemotherapy Perfusion Equipment Revenue Market Share by Country (2021–2032)
Figure 49. Mexico Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Brazil Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Argentina Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Colombia Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Middle East and Africa Hyperthermic Chemotherapy Perfusion Equipment Sales Market Share by Country (2021–2032)
Figure 54. Middle East and Africa Hyperthermic Chemotherapy Perfusion Equipment Revenue Market Share by Country (2021–2032)
Figure 55. Turkey Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Saudi Arabia Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. UAE Hyperthermic Chemotherapy Perfusion Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Global Sales Market Share of Hyperthermic Chemotherapy Perfusion Equipment by Type (2021–2032)
Figure 59. Global Revenue Market Share of Hyperthermic Chemotherapy Perfusion Equipment by Type (2021–2032)
Figure 60. Global Hyperthermic Chemotherapy Perfusion Equipment Price (US$/Unit) by Type (2021–2032)
Figure 61. Global Sales Market Share of Hyperthermic Chemotherapy Perfusion Equipment by Application (2021–2032)
Figure 62. Global Revenue Market Share of Hyperthermic Chemotherapy Perfusion Equipment by Application (2021–2032)
Figure 63. Global Hyperthermic Chemotherapy Perfusion Equipment Price (US$/Unit) by Application (2021–2032)
Figure 64. Hyperthermic Chemotherapy Perfusion Equipment Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
